NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Forecast, Price & News

$1.90

-0.02 (-1.04%)

(As of 09/22/2023 08:52 PM ET)

Compare

Today's Range: $1.88
▼
$1.95
50-Day Range: $1.90
▼
$4.38
52-Week Range: $0.84
▼
$6.24

Volume: 167,800 shs
Average Volume: 612,626 shs
Market Capitalization: $54.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.00

Rockwell Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 478.9% Upside
$11.00 Price Target
Short Interest: Healthy
5.28% of Float Sold Short
Dividend Strength: N/A
Sustainability: -2.35
Upright™ Environmental Score
News Sentiment: 0.60
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.43) to ($0.05) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

401st out of 962 stocks

Pharmaceutical Preparations Industry

167th out of 440 stocks

3.5

Analyst's Opinion

Consensus Rating
Rockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $11.00, Rockwell Medical has a forecasted upside of 478.9% from its current price of $1.90.
Amount of Analyst Coverage
Rockwell Medical has only been the subject of 1 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
5.28% of the float of Rockwell Medical has been sold short.
Short Interest Ratio / Days to Cover
Rockwell Medical has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Rockwell Medical has recently decreased by 13.18%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Rockwell Medical does not currently pay a dividend.
Dividend Growth
Rockwell Medical does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Rockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.
Environmental Sustainability
The Environmental Impact score for Rockwell Medical is -2.35.

2.0

News and Social Media Coverage

News Sentiment
Rockwell Medical has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Rockwell Medical this week, compared to 1 article on an average week.
Search Interest
Only 5 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Rockwell Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.20% of the stock of Rockwell Medical is held by insiders.
Percentage Held by Institutions
Only 22.07% of the stock of Rockwell Medical is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Rockwell Medical are expected to grow in the coming year, from ($0.43) to ($0.05) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Rockwell Medical is -2.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Rockwell Medical is -2.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Rockwell Medical has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Rockwell Medical (NASDAQ:RMTI) Stock

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including cleaning agents, 6% bleach for disinfection, citric acid descale, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

RMTI Price History

30 days | 90 days | 365 days | Advanced Chart

RMTI Stock News Headlines

September 21, 2023 | marketwatch.com

Rockwell Medical Extends Sales Pact With Top Customer DaVita >RMTI

September 21, 2023 | finance.yahoo.com

Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024

September 25, 2023 | Altimetry (Ad)

Fraud Expert: Dump these three popular stocks

A major (and legal) market manipulation scheme is about to play out. It could cost you a fortune – or double your money. You choose. Find out what he knows, here.

September 18, 2023 | finance.yahoo.com

Late-cycle stock sectors in focus amid U.S. economic uncertainty

September 7, 2023 | finance.yahoo.com

Rockwell Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023

August 15, 2023 | finance.yahoo.com

Rockwell Medical, Inc. (NASDAQ:RMTI) Q2 2023 Earnings Call Transcript

August 15, 2023 | markets.businessinsider.com

H.C. Wainwright Sticks to Their Buy Rating for Rockwell Med (RMTI)

August 14, 2023 | finance.yahoo.com

Q2 2023 Rockwell Medical Inc Earnings Call

September 25, 2023 | Altimetry (Ad)

Fraud Expert: Dump these three popular stocks

A major (and legal) market manipulation scheme is about to play out. It could cost you a fortune – or double your money. You choose. Find out what he knows, here.

August 14, 2023 | markets.businessinsider.com

Rockwell Medical Boosts Full-year Sales Outlook, Speeds Up Profitability Timeline

August 14, 2023 | markets.businessinsider.com

Why Rockwell Medical Shares Are Surging Today

August 14, 2023 | businesswire.com

Rockwell Medical Announces Second Quarter 2023 Results

August 7, 2023 | msn.com

Rockwell Medical: Upside Potential Outweighs Competition Risk

August 1, 2023 | finance.yahoo.com

VAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue Estimates

July 27, 2023 | finance.yahoo.com

Rockwell Medical (RMTI) Gains As Market Dips: What You Should Know

July 21, 2023 | finance.yahoo.com

Rockwell Medical (RMTI) Stock Sinks As Market Gains: What You Should Know

July 20, 2023 | thestreet.com

Rockwell Medical (RMTI) Stock Falls After Company Prices Public Offering

July 17, 2023 | markets.businessinsider.com

Rockwell Medical On Course To Reach Profitability By Late 2024, Analyst Says

July 17, 2023 | finance.yahoo.com

Rockwell Medical to Release Second Quarter 2023 Financial Results on Monday, August 14, 2023

July 12, 2023 | finance.yahoo.com

Institutions own 6.9% of Rockwell Medical, Inc. (NASDAQ:RMTI) shares but individual investors control 41% of the company

July 11, 2023 | msn.com

What's Going On With Rockwell Medical (RMTI) Stock

July 11, 2023 | finance.yahoo.com

Rockwell Medical Acquires Hemodialysis Concentrates Business from Evoqua Water Technologies

July 3, 2023 | finance.yahoo.com

What Makes Rockwell Medical (RMTI) a Good Fit for 'Trend Investing'

July 3, 2023 | finance.yahoo.com

Rockwell Medical (RMTI) Soars 20.0%: Is Further Upside Left in the Stock?

June 29, 2023 | finance.yahoo.com

Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical

June 27, 2023 | finance.yahoo.com

What Makes Rockwell Medical (RMTI) a Strong Momentum Stock: Buy Now?

June 26, 2023 | finance.yahoo.com

Rockwell Medical Added to Russell Microcap Index

See More Headlines

Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

RMTI Company Calendar

Last Earnings: 8/14/2023
Today: 9/24/2023
Next Earnings (Estimated): 11/13/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:RMTI
CUSIP: 77437410
CIK: 1041024
Web: www.rockwellmed.com
Phone: (248) 432-1362
Fax: 248-960-9119
Employees: 253
Year Founded: 1995

Price Target and Rating

Average Stock Price Forecast: $11.00
High Stock Price Forecast: $11.00
Low Stock Price Forecast: $11.00
Forecasted Upside/Downside: +478.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.88)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,680,000.00
Net Margins: -15.32%
Pretax Margin: -15.32%
Return on Equity: -88.74%
Return on Assets: -25.89%

Debt

Debt-to-Equity Ratio: 0.69
Current Ratio: 1.58
Quick Ratio: 1.25

Sales & Book Value

Annual Sales: $72.81 million
Price / Sales: 0.74
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.16 per share
Price / Book: 1.64

Miscellaneous

Outstanding Shares: 28,490,000
Free Float: 27,863,000
Market Cap: $54.13 million
Optionable: Optionable
Beta: 1.40

Social Links

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Dr. Mark Strobeck Ph.D. (Age 52)
Pres, CEO & Director
Comp: $643.41k

Ms. Megan C. Timmins (Age 50)
Exec. VP, Chief Legal Officer & Sec.
Comp: $518.09k

Mr. Paul E. McGarry (Age 55)
SVP of Fin. & Chief Accounting Officer

Mr. James A. McCarthy
Sr. VP of Bus. & Corp. Devel.

Mr. Timothy T. Chole
Sr. VP of Sales & Marketing

Ms. Heather R. Hunter
Sr. VP & Chief Corp. Affairs Officer

Mr. David J. Kull (Age 55)
Sec.

Mr. Jason Finkelstein
Investor Relations Representative

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

RMTI Stock - Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RMTI shares.
View RMTI analyst ratings or view top-rated stocks.
What is Rockwell Medical's stock price forecast for 2023?: 1 brokers have issued twelve-month target prices for Rockwell Medical's stock. Their RMTI share price forecasts range from $11.00 to $11.00. On average, they expect the company's stock price to reach $11.00 in the next year. This suggests a possible upside of 478.9% from the stock's current price.
View analysts price targets for RMTI or view top-rated stocks among Wall Street analysts.
How have RMTI shares performed in 2023?: Rockwell Medical's stock was trading at $1.0150 on January 1st, 2023. Since then, RMTI shares have increased by 87.2% and is now trading at $1.90.
View the best growth stocks for 2023 here.
When is Rockwell Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our RMTI earnings forecast.
How were Rockwell Medical's earnings last quarter?: Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings data on Monday, August, 14th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.06. The firm had revenue of $18.08 million for the quarter, compared to the consensus estimate of $18.08 million. Rockwell Medical had a negative trailing twelve-month return on equity of 88.74% and a negative net margin of 15.32%. During the same period in the previous year, the business earned ($0.56) EPS.
When did Rockwell Medical's stock split?: Shares of Rockwell Medical reverse split on the morning of Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.
What guidance has Rockwell Medical issued on next quarter's earnings?: Rockwell Medical issued an update on its FY 2023 earnings guidance on Sunday, September, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.00 million-$86.00 million, compared to the consensus revenue estimate of $86.08 million.
What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?: 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).
What is Rockwell Medical's stock symbol?: Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."
Who are Rockwell Medical's major shareholders?: Rockwell Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Richmond Brothers Inc. (3.07%), Renaissance Technologies LLC (2.54%), Stratos Wealth Partners LTD. (1.09%), BlackRock Inc. (0.87%), Geode Capital Management LLC (0.77%) and Perkins Capital Management Inc. (0.58%).
View institutional ownership trends.
How do I buy shares of Rockwell Medical?: Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Rockwell Medical's stock price today?: One share of RMTI stock can currently be purchased for approximately $1.90.
How much money does Rockwell Medical make?: Rockwell Medical (NASDAQ:RMTI) has a market capitalization of $54.13 million and generates $72.81 million in revenue each year. The company earns $-18,680,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.
How many employees does Rockwell Medical have?: The company employs 253 workers across the globe.
How can I contact Rockwell Medical?: Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The official website for the company is www.rockwellmed.com. The company can be reached via phone at (248) 432-1362, via email at invest@rockwellmed.com, or via fax at 248-960-9119.

This page (NASDAQ:RMTI) was last updated on 9/25/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial